Page 152 - Read Online

2001;120:1285-8. C viral infection: Thl/Th2 responses and the role of cytokines. Clin
84. Iredale JP, Benyon RC, Pickering J, McCullen M, Northrop M, Biochem 2001;34:167-71.
Pawley S, Hovell C, Arthur MJ. Mechanisms of spontaneous 95. Goyal A, Kazim SN, Sakhuja P, Malhotra V, Arora N, Sarin SK.
resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and Association of TNF-beta polymorphism with disease severity among
reduced hepatic expression of metalloproteinase inhibitors. J Clin patients infected with hepatitis C virus. J Med Virol 2004;72:60-5.
Invest 1998;102:538-49. 96. Cacciarelli TV, Martintez OM, Gish RG, Villarnueva JC, Krams SM.
85. Gressner AM. Liver fibrosis: perspectives in pathobiochemical Immunoregulatory cytokines in chronic hepatitis C virus infection:
research and clinical outlook. Eur J Clin Chem Clin Biochem
1991;29:293-311. pre-and posttreatment with interferon alfa. Hepatology 1996;24:6-9.
86. Svegliati Baroni G, D’Ambrosio L, Ferretti G, Casini A, Di Sario 97. Lu DH, Guo XY, Qin SY, Luo W, Huang XL, Chen M, Wang JX, Ma
A, Salzano R, Ridolfi F, Saccomanno S, Jezequel AM, Benedetti SJ, Yang XW, Jiang HX. Interleukin-22 ameliorates liver fibrogenesis
A. Fibrogenic effect of oxidative stress on rat hepatic stellate cells. by attenuating hepatic stellate cell activation and downregulating
Hepatology 1998;27:720-6. the levels of inflammatory cytokines. World J Gastroenterol
87. Thirunavukkarasu C, Watkins S, Harvey SAK, Gandhi CR. 2015;21:1531-45.
Superoxide-induced apoptosis of activated rat hepatic stellate cells. 98. Hsia CY, Huo TI, Chiang SY, Lu MF, Sun CL, Wu JC, Lee PC, Chi
J Hepatol 2004;41:567-75. CW, Lui WY, Lee SD. Evaluation of interleukin-6, interleukin-10 and
88. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest 2005;115:209-18. human hepatocyte growth factor as tumor markers of hepatocellular
89. Yee LJ, Tang J, Herrera J, Kaslow RA, van Leeuwen DJ. Tumor carcinoma. Eur J Surg Oncol 2007;33:208-12.
necrosis factor gene polymorphisms in patients with cirrhosis from 99. El-Medany OM, Abdel Wahab KS, Abu Shady EA, Gad El-Hak
chronic hepatitis C virus infection. Genes Immun 2000;1:386-90.
90. Bataller R, North KE, Brenner DA. Genetic polymorphisms and N. Chronic liver disease and hepatitis C virus in Egyptian patients.
the progression of liver fibrosis: a critical appraisal. Hepatology Hepatogastroenterology 1999;46:1895-903.
2003;37:493-503. 100. Stoll-Keller F, Schvoerer E, Thumann C, Navas MC, Aubertin
91. Han YP, Zhou L, Wang J, Xiong S, Garner WL, French SW, AM. Immunomodulating effect of HCV during the development of
Tsukamoto H. Essential role of matrix metalloproteinases in chronic hepatitis C: toward new therapeutic approaches. Bull Acad
interleukin-1-induced myofibroblastic activation of hepatic stellate Natl Med 2003;187:1147-60; discussion 1160-1. (in French)
cell in collagen. J Biol Chem 2004;279:4820-8. 101. Elrefaei M, El-Sheikh N, Kamal K, Cao H. HCV-specific CD27-
92. Marek B, Kajdaniuk D, Mazurek U, Janczewska-Kazek E, Kos- CD28- memory T cells are depleted in hepatitis C virus and
Kudla B, Strzalka B, Fila A, Niedziolka D, Beniowski M, Ostrowska Schistosoma mansoni co-infection. Immunology 2003;110:513-8.
Z, Borgiel-Marek H, Kajdaniuk J, Sieminska L, Nowak M, Wilczok 102. Marotta F, Vangieri B, Cecere A, Gattoni A. The pathogenesis
T, Pakula D, Filipczyk P. TGF-beta l mRNA expression in liver of hepatocellular carcinoma is multifactorial event. Novel
biopsy specimens and TGF-beta l serum levels in patients with
chronic hepatitis C before and after antiviral therapy. J Clin Pharm immunological treatment in prospect. Clin Ter 2004;155:187-99.
Ther 2005;30:271-7. 103. Lee S, Margolin K. Cytokines in cancer immunotherapy. Cancers
93. Nelson DR, Lauwers GY, Lau J Y, Davis GL. Interleukin 10 treatment (Basel) 2011;3:3856-93.
reduces fibrosis in patients with chronic hepatitis C: a pilot trial of 104. Fainboim L, Chernavsky A, Paladino N, Flores AC, Arruvito L.
interferon nonresponders. Gastroenterology 2000;118:655-60. Cytokines and chronic liver disease. Cytokine Growth Factor Rev
94. Jacobson Brown PM, Neuman MG. Immunopathogenesis of hepatitis 2007;18:143-57.

Hepatoma Research | Volume 2 | June 1, 2016 143